{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:43:09Z","timestamp":1787312589627,"version":"build-2736575974"},"reference-count":59,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Psychological Medicine"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Oculogyric crisis (OGC) is a form of acute dystonia characterized by sustained dystonic, conjugate, and upward deviation of the eyes. It was initially reported in patients with postencephalitic parkinsonism. But later, other factors such as medications, movement disorders, metabolic disorders, and focal brain lesions were also found to be associated with OGC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The literature regarding OGC was searched via PubMed, Google Scholar, and through citations in relevant articles till December 2019, with keywords including OGC, oculogyric eye movements, tonic eye movement, neuroleptics and OGC, antipsychotics and OGC, and all combinations of these. Only original articles (abstract or full text) that were published in the English language were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Hypodopaminergic state is implicated in the pathogenesis of OGC. Common risk factors are younger age, male sex, severe illness, high neuroleptic dose, parenteral administration of neuroleptics, high potency of neuroleptic drugs, abrupt discontinuation of anticholinergic medication, and family history of dystonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>OGC is an acute dystonic reaction leading to tonic upward deviation of eyes. It is associated with various neurometabolic, neurodegenerative, and movement disorders and medications such as antipsychotics, antiemetics, antidepressants, antiepileptics, and antimalarials. OGC can adversely impact the compliance and prognosis of the primary illness. Hence, it needs to be managed at earlier stages with appropriate medication, primarily anticholinergics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0253717620942096","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T03:51:51Z","timestamp":1599105111000},"page":"5-9","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":28,"title":["Spotlight on Oculogyric Crisis: A Review"],"prefix":"10.1177","volume":"43","author":[{"given":"Pankaj","family":"Mahal","sequence":"first","affiliation":[{"name":"Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navratan","family":"Suthar","sequence":"additional","affiliation":[{"name":"Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Nebhinani","sequence":"additional","affiliation":[{"name":"Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"bibr1-0253717620942096","doi-asserted-by":"crossref","unstructured":"Solberg M, Koht J. Oculogyric crises. Tremor Hyperkinetic Mov [Internet] 2017 [cited Apr 17, 2019]; 7, https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5623758\/ (accessed July 27, 2020)","DOI":"10.5334\/tohm.390"},{"key":"bibr2-0253717620942096","doi-asserted-by":"crossref","unstructured":"Barow E, Schneider SA, Bhatia KP, Ganos C. Oculogyric crises:Etiology, pathophysiology and therapeutic approaches. Parkinsonism Relat Disord 2017; 36: 3\u20139.","DOI":"10.1016\/j.parkreldis.2016.11.012"},{"key":"bibr3-0253717620942096","doi-asserted-by":"crossref","unstructured":"Abe K. Psychiatric symptoms associated with oculogyric crisis: A review of literature for the characterization of antipsychotic-induced episodes. World J Biol Psychiatry 2006; 7(2): 70\u201374.","DOI":"10.1080\/15622970500222443"},{"key":"bibr4-0253717620942096","doi-asserted-by":"crossref","unstructured":"Koban Y, Ekinci M, Cagatay HH, Yazar Z. Oculogyric crisis in a patient taking metoclopramide. Clin Ophthalmol 2014; 8: 567\u2013569.","DOI":"10.2147\/OPTH.S60041"},{"key":"bibr5-0253717620942096","volume-title":"StatPearls","author":"Lewis K","year":"2019"},{"key":"bibr6-0253717620942096","doi-asserted-by":"crossref","unstructured":"Spina E, Sturiale V, Valvo S . Prevalence of acute dystonic reactions associated with neuroleptic treatment with and without anticholinergic prophylaxis. Int Clin Psychopharmacol 1993; 8(1): 21\u201324.","DOI":"10.1097\/00004850-199300810-00003"},{"key":"bibr7-0253717620942096","doi-asserted-by":"crossref","unstructured":"Gardner DM, Abidi S, Ursuliak Z . Incidence of oculogyric crisis and long-term outcomes with second-generation antipsychotics in a first-episode psychosis program. J Clin Psychopharmacol 2015; 35(6): 715\u2013718.","DOI":"10.1097\/JCP.0000000000000411"},{"key":"bibr8-0253717620942096","doi-asserted-by":"crossref","unstructured":"Wyllie E, L\u00fcders H, Morris HH, Lesser RP, Dinner DS. The lateralizing significance of versive head and eye movements during epileptic seizures. Neurology 1986; 36(5): 606\u2013611.","DOI":"10.1212\/WNL.36.5.606"},{"key":"bibr9-0253717620942096","doi-asserted-by":"crossref","unstructured":"Salmina C, Taddeo I, Falesi M . Paroxysmal tonic upgaze in normal children: A case series and a review of the literature. Eur J Paediatr Neurol 2012; 16(6): 683\u2013687.","DOI":"10.1016\/j.ejpn.2012.04.004"},{"key":"bibr10-0253717620942096","doi-asserted-by":"crossref","unstructured":"Jankovic J, Stone L. Dystonic tics in patients with Tourette\u2019s syndrome. Mov Disord 1991; 6(3): 248\u2013252.","DOI":"10.1002\/mds.870060309"},{"key":"bibr11-0253717620942096","unstructured":"Gold DR. Eye movement disorders: Conjugate gaze abnormalities [Internet]. In: Liu GT, Volpe NJ, Galetta SL (eds)\n                      Liu, Volpe, and Galetta\u2019s Neuro-Ophthalmology\n                      . 3rd ed. Elsevier; 2019 [cited Mar 26, 2020], pp. 549\u201384, http:\/\/www.sciencedirect.com\/science\/article\/pii\/B978032334044100016X (accessed July 27, 2020)."},{"key":"bibr12-0253717620942096","doi-asserted-by":"crossref","unstructured":"Yildiz Y, Pektas E, Tokatli A, Haliloglu G. Hereditary dopamine transporter deficiency syndrome: Challenges in diagnosis and treatment. Neuropediatrics 2017; 48(1): 49\u201352.","DOI":"10.1055\/s-0036-1593372"},{"key":"bibr13-0253717620942096","doi-asserted-by":"crossref","unstructured":"Portaro S, Gugliandolo A, Scionti D  When dysphoria is not a primary mental state: A case report of the role of the aromatic L-aminoacid decarboxylase. Medicine (Baltimore) 2018; 97(22): e10953.","DOI":"10.1097\/MD.0000000000010953"},{"key":"bibr14-0253717620942096","doi-asserted-by":"crossref","unstructured":"Lee LK, Cheung KM, Cheng WW . A rare cause of severe diarrhoea diagnosed by urine metabolic screening: aromatic L-amino acid decarboxylase deficiency. Hong Kong Med J 2014; 20(2): 161\u2013164.","DOI":"10.12809\/hkmj133922"},{"key":"bibr15-0253717620942096","doi-asserted-by":"crossref","unstructured":"Wassenberg T, Molero-Luis M, Jeltsch K . Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Orphanet J Rare Dis 2017; 12(1): 12.","DOI":"10.1186\/s13023-016-0522-z"},{"key":"bibr16-0253717620942096","doi-asserted-by":"crossref","unstructured":"De Giorgis V, Varesio C, Baldassari C . Atypical manifestations in Glut1 deficiency syndrome. J Child Neurol 2016; 31(9): 1174\u20131180.","DOI":"10.1177\/0883073816650033"},{"key":"bibr17-0253717620942096","doi-asserted-by":"crossref","unstructured":"Jacobsen JC, Wilson C, Cunningham V . Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder. J Inherit Metab Dis 2016; 39(2): 305\u2013308.","DOI":"10.1007\/s10545-015-9897-6"},{"key":"bibr18-0253717620942096","doi-asserted-by":"crossref","unstructured":"Leuzzi V, Carducci CA, Carducci CL . Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency. Clin Genet 2010; 77(3): 249\u2013257.","DOI":"10.1111\/j.1399-0004.2009.01306.x"},{"key":"bibr19-0253717620942096","doi-asserted-by":"crossref","unstructured":"Almannai M, Felemban R, Saleh MA . 6-Pyruvoyltetrahydropterin synthase deficiency: Review and report of 28 Arab subjects. Pediatr Neurol 2019; 96: 40\u201347.","DOI":"10.1016\/j.pediatrneurol.2019.02.008"},{"key":"bibr20-0253717620942096","doi-asserted-by":"crossref","unstructured":"Rohani M, Shahidi G, Vali F . Oculogyric crises in PLA2G6 associated neurodegeneration. Parkinsonism Relat Disord 2018; 52: 111\u2013112.","DOI":"10.1016\/j.parkreldis.2018.03.010"},{"key":"bibr21-0253717620942096","doi-asserted-by":"crossref","unstructured":"Pironti E, Granata F, Cucinotta F . Electroclinical history of a five-year-old girl with GRIN1-related early-onset epileptic encephalopathy: a video-case study. Epileptic Disord Int Epilepsy J Videotape 2018; 20(5): 423\u2013427.","DOI":"10.1684\/epd.2018.0992"},{"key":"bibr22-0253717620942096","doi-asserted-by":"crossref","unstructured":"Ohba C, Shiina M, Tohyama J . GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders. Epilepsia 2015; 56(6): 841\u2013848.","DOI":"10.1111\/epi.12987"},{"key":"bibr23-0253717620942096","unstructured":"Parker JC, Dyer ML, Paulsen WA. Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis. J Clin Neuroophthalmol 1987; 7(4): 244\u2013249."},{"key":"bibr24-0253717620942096","doi-asserted-by":"crossref","unstructured":"FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov Disord 1990; 5(3): 195\u2013202.","DOI":"10.1002\/mds.870050303"},{"key":"bibr25-0253717620942096","doi-asserted-by":"crossref","unstructured":"Grattan-Smith PJ, Wevers RA, Steenbergen-Spanjers GC . Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy. Mov Disord 2002; 17(2): 354\u2013359.","DOI":"10.1002\/mds.10095"},{"key":"bibr26-0253717620942096","doi-asserted-by":"crossref","unstructured":"Pons R, Serrano M, Ormazabal A . Tyrosine hydroxylase deficiency in three Greek patients with a common ancestral mutation. Mov Disord 2010; 25(8): 1086\u20131090.","DOI":"10.1002\/mds.23002"},{"key":"bibr27-0253717620942096","doi-asserted-by":"crossref","unstructured":"Williams DR, Hadeed A, al-Din ASN, Wreikat A-L, Lees AJ. Kufor Rakeb disease: Autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov Disord 2005; 20(10): 1264\u20131271.","DOI":"10.1002\/mds.20511"},{"key":"bibr28-0253717620942096","doi-asserted-by":"crossref","unstructured":"Taipa R, Moreira B, Fran\u00e7a M, Maia LF. A case of haemophagocytic syndrome presenting with oculogyric crises. J Neurol Neurosurg Psychiatry 2010; 81(4): 469\u2013471.","DOI":"10.1136\/jnnp.2009.177097"},{"key":"bibr29-0253717620942096","doi-asserted-by":"crossref","unstructured":"Friedman J, Roze E, Abdenur JE . Sepiapterin reductase deficiency: A treatable mimic of cerebral palsy. Ann Neurol 2012; 71(4): 520\u2013530.","DOI":"10.1002\/ana.22685"},{"key":"bibr30-0253717620942096","doi-asserted-by":"crossref","unstructured":"Koht J, Rengmark A, Opladen T . Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene. Acta Neurol Scand Suppl 2014; (198): 7\u201312.","DOI":"10.1111\/ane.12230"},{"key":"bibr31-0253717620942096","doi-asserted-by":"crossref","unstructured":"Horvath GA, Stockler-Ipsiroglu SG, Salvarinova-Zivkovic R . Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: Evidence of a phenotypic continuum between dominant and recessive forms. Mol Genet Metab 2008; 94(1): 127\u2013131.","DOI":"10.1016\/j.ymgme.2008.01.003"},{"key":"bibr32-0253717620942096","doi-asserted-by":"crossref","unstructured":"Devinsky O. Neuroanatomy of Gilles de la Tourette\u2019s syndrome: Possible midbrain involvement. Arch Neurol 1983; 40(8): 508\u2013514.","DOI":"10.1001\/archneur.1983.04210070048013"},{"key":"bibr33-0253717620942096","doi-asserted-by":"crossref","unstructured":"Matsumura K, Sakuta M. Oculogyric crisis in acute herpetic brainstem encephalitis. J Neurol Neurosurg Psychiatry 1987; 50(3): 365\u2013366.","DOI":"10.1136\/jnnp.50.3.365"},{"key":"bibr34-0253717620942096","unstructured":"Leea JH, Lyoob CH, Leec JG, Leeb MS. Oculogyric crisis associated with disulfiram-induced pallidonigral lesion. J Mov Disord [Internet] [cited Apr 21, 2019], http:\/\/www.e-jmd.org\/journal\/view.php?number=85 (accessed July 27, 2020)."},{"key":"bibr35-0253717620942096","doi-asserted-by":"crossref","unstructured":"Heimburger RF. Positional oculogyric crises: Case report. J Neurosurg 1988; 69(6): 951\u2013953.","DOI":"10.3171\/jns.1988.69.6.0951"},{"key":"bibr36-0253717620942096","doi-asserted-by":"crossref","unstructured":"Nebhinani N, Suthar N. Oculogyric crisis with atypical antipsychotics: A case series. Indian J Psychiatry 2017; 59(4): 499.","DOI":"10.4103\/psychiatry.IndianJPsychiatry_211_17"},{"key":"bibr37-0253717620942096","doi-asserted-by":"crossref","unstructured":"Nebhinani N, Avasthi A, Modi M. Oculogyric crisis with clozapine: A case report and review of similar case reports in the literature. Indian J Psychol Med 2015; 37(3): 342.","DOI":"10.4103\/0253-7176.162946"},{"key":"bibr38-0253717620942096","doi-asserted-by":"crossref","unstructured":"Jitprapaikulsan J, Srivanitchapoom P. Acute dystonic reaction following general anesthetic agent use. Tremor Hyperkinetic Mov N Y N 2017; 7: 514.","DOI":"10.5334\/tohm.392"},{"key":"bibr39-0253717620942096","unstructured":"Nahhas N, Conant A, Hamilton E . TUBB4A-Related Leukodystrophy [Internet]. In: Adam MP, Ardinger HH, Pagon RA . (ed) GeneReviews\u00ae. Seattle, WA: University of Washington, 1993 [cited Apr 24, 2020], http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK395611\/ (accessed July 27, 2020)."},{"key":"bibr40-0253717620942096","doi-asserted-by":"crossref","unstructured":"Wong LH, Tan E. Anti-tuberculosis medication-induced oculogyric crisis and the importance of proper history taking. Int Med Case Rep J 2017; 10: 341\u2013344.","DOI":"10.2147\/IMCRJ.S147779"},{"key":"bibr41-0253717620942096","doi-asserted-by":"crossref","unstructured":"Choi JK, Hong JY. Acute cervical dystonia induced by clebopride. Case Rep Neurol Med 2017; 2017: 2834349.","DOI":"10.1155\/2017\/2834349"},{"key":"bibr42-0253717620942096","doi-asserted-by":"crossref","unstructured":"Jacob S, Ly H, Villenueva RJ, Gupta HV. Acute dystonic reaction in a patient with Parkinson\u2019s disease after diphenhydramine withdrawal. Acta Neurol Belg 2017; 117(1): 345\u2013356.","DOI":"10.1007\/s13760-016-0626-1"},{"key":"bibr43-0253717620942096","doi-asserted-by":"crossref","unstructured":"Slow EJ, Lang AE. Oculogyric crises: A review of phenomenology, etiology, pathogenesis, and treatment. Mov Disord 2017; 32(2): 193\u2013202.","DOI":"10.1002\/mds.26910"},{"key":"bibr44-0253717620942096","doi-asserted-by":"crossref","unstructured":"Schneider SA, Udani V, Sankhla CS, Bhatia KP. Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs. Mov Disord 2009; 24(8): 1226\u20131229.","DOI":"10.1002\/mds.22532"},{"key":"bibr45-0253717620942096","doi-asserted-by":"crossref","unstructured":"Aramideh M, Bour LJ, Koelman JH, Speelman JD, Ongerboer de Visser BW. Abnormal eye movements in blepharospasm and involuntary levator palpebrae inhibition: Clinical and pathophysiological considerations. Brain J Neurol 1994; 117 ( Pt 6): 1457\u20131474.","DOI":"10.1093\/brain\/117.6.1457"},{"key":"bibr46-0253717620942096","doi-asserted-by":"crossref","unstructured":"Teo JT, Edwards MJ, Bhatia K. Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis. Mov Disord 2012; 27(10): 1205\u20131215.","DOI":"10.1002\/mds.25107"},{"key":"bibr47-0253717620942096","doi-asserted-by":"crossref","unstructured":"Prisco S, Esposito E. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br J Pharmacol 1995; 116(2): 1923\u20131931.","DOI":"10.1111\/j.1476-5381.1995.tb16684.x"},{"key":"bibr48-0253717620942096","doi-asserted-by":"crossref","unstructured":"Keepers GA, Casey DE. Prediction of Neuroleptic-Induced Dystonia. J Clin Psychopharmacol 1987; 7(5): 342.","DOI":"10.1097\/00004714-198710000-00011"},{"key":"bibr49-0253717620942096","doi-asserted-by":"crossref","unstructured":"Aguilar EJ, Keshavan MS, Mart\u00ednez-Quiles MD . Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry 1994; 151(12): 1819\u20131821.","DOI":"10.1176\/ajp.151.12.1819"},{"key":"bibr50-0253717620942096","unstructured":"Chakos MH, Mayerhoff DI, Loebel AD, Alvir JM, Lieberman JA. Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia. Psychopharmacol Bull 1992; 28(1): 81\u201386."},{"key":"bibr51-0253717620942096","doi-asserted-by":"crossref","unstructured":"Sachdev PS. Neuroleptic-induced movement disorders: An overview. Psychiatr Clin North Am 2005; 28(1): 255\u201374, x.","DOI":"10.1016\/j.psc.2004.10.004"},{"key":"bibr52-0253717620942096","doi-asserted-by":"crossref","unstructured":"Jhee SS, Zarotsky V, Mohaupt SM, Yones CL, Sims SJ. Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol. Ann Pharmacother 2003; 37(10): 1434\u20131437.","DOI":"10.1345\/aph.1C389"},{"key":"bibr53-0253717620942096","doi-asserted-by":"crossref","unstructured":"Jamal Omidi S, Fernandez BacaVaca G, Lacuey N . Episodic gaze deviation in multiple sclerosis: Versive seizures or oculogyric crises? J Clin Neurosci 2018; 58: 201\u2013203.","DOI":"10.1016\/j.jocn.2018.10.012"},{"key":"bibr54-0253717620942096","doi-asserted-by":"crossref","unstructured":"F-L Tianyi, Agbor VN, Njim T. Metoclopramide induced acute dystonic reaction: A case report. BMC Res Notes 2017; 10(1): 32.","DOI":"10.1186\/s13104-016-2342-6"},{"key":"bibr55-0253717620942096","doi-asserted-by":"crossref","unstructured":"Cheng K-J, Yeh T-C, Ku S-C, Tseng Y-T, Liang C-S. Electroconvulsive therapy for anticholinergic and benzodiazepine nonresponsive tardive oculogyric crisis: A case report. Am J Ther 2020; 27: e412\u2013e413.","DOI":"10.1097\/MJT.0000000000000971"},{"key":"bibr56-0253717620942096","doi-asserted-by":"crossref","unstructured":"Zurowski M, McDonald WM, Fox S, Marsh L. Psychiatric comorbidities in dystonia: Emerging concepts. Mov Disord 2013; 28(7): 914\u2013920.","DOI":"10.1002\/mds.25501"},{"key":"bibr57-0253717620942096","doi-asserted-by":"crossref","unstructured":"Das S, Agrawal A. Lurasidone-induced oculogyric crisis. Indian J Psychol Med 2017; 39(5): 719\u2013720.","DOI":"10.4103\/IJPSYM.IJPSYM_266_17"},{"key":"bibr58-0253717620942096","doi-asserted-by":"crossref","unstructured":"Wagle Shukla A, Brown R, Heese K . High rates of fatigue and sleep disturbances in dystonia. Int J Neurosci 2016; 126(10): 928\u2013935.","DOI":"10.3109\/00207454.2015.1085035"},{"key":"bibr59-0253717620942096","doi-asserted-by":"crossref","unstructured":"Skokou M, E-E Tsermpini, Giamarelou A, Gogos A, Gourzis P. Tardive dystonia due to D2 antagonists and other agents. Dystonia - Differ Prospects [Internet] 2018 [cited Apr 24, 2020], https:\/\/www.intechopen.com\/books\/dystonia-different-prospects\/tardive-dystonia-due-to-d2-antagonists-and-other-agents (accessed July 27, 2020).","DOI":"10.5772\/intechopen.78760"}],"container-title":["Indian Journal of Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0253717620942096","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0253717620942096","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0253717620942096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:42:09Z","timestamp":1777653729000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0253717620942096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1177\/0253717620942096"],"URL":"https:\/\/doi.org\/10.1177\/0253717620942096","relation":{},"ISSN":["0253-7176","0975-1564"],"issn-type":[{"value":"0253-7176","type":"print"},{"value":"0975-1564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}